These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2876649)

  • 1. Combined alprazolam and neuroleptic drug in treating schizophrenia.
    Bacher NM; Lewis HA; Field PB
    Am J Psychiatry; 1986 Oct; 143(10):1311-3. PubMed ID: 2876649
    [No Abstract]   [Full Text] [Related]  

  • 2. Alprazolam-neuroleptic combination in schizophrenia.
    Lipinski JF; Cohen BM
    Am J Psychiatry; 1986 Nov; 143(11):1501-2. PubMed ID: 2877587
    [No Abstract]   [Full Text] [Related]  

  • 3. Survey of the adjuvant use of benzodiazepines for treating outpatients with schizophrenia.
    Pecknold JC
    J Psychiatry Neurosci; 1993 Mar; 18(2):82-4. PubMed ID: 8096393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive alprazolam for schizophrenia with panic anxiety: clinical observation and pathogenetic implications.
    Kahn JP; Puertollano MA; Schane MD; Klein DF
    Am J Psychiatry; 1988 Jun; 145(6):742-4. PubMed ID: 2897166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic augmentation with alprazolam: clinical effects and pharmacokinetic correlates.
    Douyon R; Angrist B; Peselow E; Cooper T; Rotrosen J
    Am J Psychiatry; 1989 Feb; 146(2):231-4. PubMed ID: 2563211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alprazolam as a neuroleptic adjunct in the emergency treatment of schizophrenia.
    Barbee JG; Mancuso DM; Freed CR; Todorov AA
    Am J Psychiatry; 1992 Apr; 149(4):506-10. PubMed ID: 1348161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophrenia.
    Wolkowitz OM; Pickar D; Doran AR; Breier A; Tarell J; Paul SM
    Am J Psychiatry; 1986 Jan; 143(1):85-7. PubMed ID: 2867690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alprazolam augmentation of neuroleptics in schizophrenia.
    Wolkowitz OM; Breier A; Doran A; Lucas P; Kelsoe J; Paul SM; Pickar D
    Am J Psychiatry; 1989 Aug; 146(8):1087-8. PubMed ID: 2568762
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia.
    Meltzer HY; Sommers AA; Luchins DJ
    J Clin Psychopharmacol; 1986 Dec; 6(6):329-38. PubMed ID: 2879856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alprazolam augmentation of antipsychotic pharmacotherapy?
    Thienhaus OJ; Somoza E; Nobilski M
    Arch Gen Psychiatry; 1989 Nov; 46(11):1052-3. PubMed ID: 2818141
    [No Abstract]   [Full Text] [Related]  

  • 11. Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary results.
    Wolkowitz OM; Breier A; Doran A; Kelsoe J; Lucas P; Paul SM; Pickar D
    Arch Gen Psychiatry; 1988 Jul; 45(7):664-71. PubMed ID: 3289524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind comparison of alprazolam, diazepam, and placebo for the treatment of negative schizophrenic symptoms.
    Csernansky JG; Riney SJ; Lombrozo L; Overall JE; Hollister LE
    Arch Gen Psychiatry; 1988 Jul; 45(7):655-9. PubMed ID: 3289523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A differential effect profile of neuroleptic therapy of acute schizophrenic patients? Results of a clinico-naturalistic study].
    Schmidt LG; Siemetzki H
    Nervenarzt; 1988 Dec; 59(12):721-6. PubMed ID: 2905770
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute administration of alprazolam has no effect on plasma homovanillic acid concentration in normal subjects.
    Zemishlany Z; Davidson M; Jaff S; McQueeney R
    Schizophr Res; 1991; 5(1):81-3. PubMed ID: 1677266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Education groups in neuroleptic treatment of schizophrenic patients].
    Gaillard P; Degiovanni A; Parrot F
    Ann Med Psychol (Paris); 1993 Apr; 151(4):340-2. PubMed ID: 7904433
    [No Abstract]   [Full Text] [Related]  

  • 16. Exacerbation of schizophrenia associated with amantadine.
    Nestelbaum Z; Siris SG; Rifkin A; Klar H; Reardon GT
    Am J Psychiatry; 1986 Sep; 143(9):1170-1. PubMed ID: 2875665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment-resistant schizophrenia: reviewing the options and identifying the way forward.
    Hellewell JS
    J Clin Psychiatry; 1999; 60 Suppl 23():14-9. PubMed ID: 10625195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-adrenergic antagonists in psychosis: is improvement due to treatment of neuroleptic-induced akathisia?
    Lipinski JF; Keck PE; McElroy SL
    J Clin Psychopharmacol; 1988 Dec; 8(6):409-16. PubMed ID: 2906947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
    Johnson DA
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial of fluoxetine added to neuroleptics for treatment-resistant schizophrenic patients.
    Goff DC; Brotman AW; Waites M; McCormick S
    Am J Psychiatry; 1990 Apr; 147(4):492-4. PubMed ID: 1969245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.